The Market Doesn't Like What It Sees From Tianda Pharmaceuticals Limited's (HKG:455) Revenues Yet
May 28
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedMay 31, 2025
DataAggregated Company Financials
Companies40
- 7D6.2%
- 3M36.5%
- 1Y34.8%
- YTD41.4%
The Pharma industry is up 6.2% in the last week, with CSPC Pharmaceutical Group up 22%. In the same time, Grand Pharmaceutical Group was down 6.0%. This means that the industry has gained 32% over the past year. Looking forward, earnings are forecast to grow by 11% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 31 May 2025 | HK$597.0b | HK$475.4b | HK$28.7b | 10.9x | 20.8x | 1.3x |
| Mon, 28 Apr 2025 | HK$507.4b | HK$466.9b | HK$28.6b | 10.6x | 17.7x | 1.1x |
| Wed, 26 Mar 2025 | HK$467.7b | HK$466.0b | HK$33.5b | 9x | 14x | 1x |
| Fri, 21 Feb 2025 | HK$442.5b | HK$463.0b | HK$31.9b | 8.6x | 13.9x | 1x |
| Sun, 19 Jan 2025 | HK$401.9b | HK$459.6b | HK$31.7b | 8.1x | 12.7x | 0.9x |
| Tue, 17 Dec 2024 | HK$431.1b | HK$461.4b | HK$31.8b | 8.4x | 13.5x | 0.9x |
| Thu, 14 Nov 2024 | HK$436.8b | HK$466.1b | HK$32.3b | 8.2x | 13.5x | 0.9x |
| Sat, 12 Oct 2024 | HK$513.6b | HK$474.1b | HK$32.9b | 7.9x | 15.6x | 1.1x |
| Mon, 09 Sep 2024 | HK$438.6b | HK$474.4b | HK$32.9b | 7.9x | 13.3x | 0.9x |
| Wed, 07 Aug 2024 | HK$433.7b | HK$464.8b | HK$33.0b | 7.4x | 13.2x | 0.9x |
| Fri, 05 Jul 2024 | HK$437.3b | HK$461.1b | HK$33.7b | 7.8x | 13x | 0.9x |
| Sun, 02 Jun 2024 | HK$456.4b | HK$464.5b | HK$34.0b | 8.2x | 13.4x | 1x |
| Tue, 30 Apr 2024 | HK$462.1b | HK$463.9b | HK$33.8b | 7.6x | 13.7x | 1x |
| Thu, 28 Mar 2024 | HK$458.9b | HK$468.2b | HK$33.6b | 7.8x | 13.7x | 1x |
| Sat, 24 Feb 2024 | HK$447.7b | HK$470.9b | HK$33.6b | 7.8x | 13.3x | 1x |
| Mon, 22 Jan 2024 | HK$420.2b | HK$472.3b | HK$33.8b | 6.9x | 12.4x | 0.9x |
| Wed, 20 Dec 2023 | HK$470.5b | HK$472.3b | HK$33.8b | 7.5x | 13.9x | 1x |
| Fri, 17 Nov 2023 | HK$506.0b | HK$469.8b | HK$32.0b | 6.9x | 15.8x | 1.1x |
| Sun, 15 Oct 2023 | HK$442.5b | HK$469.3b | HK$31.5b | 7.2x | 14x | 0.9x |
| Tue, 12 Sep 2023 | HK$430.9b | HK$469.7b | HK$31.6b | 6.8x | 13.6x | 0.9x |
| Thu, 10 Aug 2023 | HK$452.2b | HK$446.1b | HK$27.8b | 8.8x | 16.3x | 1x |
| Sat, 08 Jul 2023 | HK$476.9b | HK$445.9b | HK$27.8b | 9.4x | 17.2x | 1.1x |
| Mon, 05 Jun 2023 | HK$512.0b | HK$449.2b | HK$28.0b | 8.5x | 18.3x | 1.1x |
| Wed, 03 May 2023 | HK$570.3b | HK$453.4b | HK$28.5b | 9x | 20x | 1.3x |
| Fri, 31 Mar 2023 | HK$536.0b | HK$444.9b | HK$35.0b | 9.1x | 15.3x | 1.2x |
| Sun, 26 Feb 2023 | HK$601.4b | HK$443.4b | HK$35.0b | 11.7x | 17.2x | 1.4x |
| Tue, 24 Jan 2023 | HK$635.9b | HK$447.3b | HK$35.6b | 10.7x | 17.9x | 1.4x |
| Thu, 22 Dec 2022 | HK$590.7b | HK$441.7b | HK$34.7b | 10.3x | 17x | 1.3x |
| Sat, 19 Nov 2022 | HK$616.9b | HK$436.9b | HK$33.9b | 9.5x | 18.2x | 1.4x |
| Mon, 17 Oct 2022 | HK$535.5b | HK$513.5b | HK$38.9b | 8.2x | 13.8x | 1x |
| Wed, 14 Sep 2022 | HK$549.4b | HK$520.9b | HK$40.9b | 9.7x | 13.4x | 1.1x |
| Fri, 12 Aug 2022 | HK$594.4b | HK$514.4b | HK$51.6b | 8.1x | 11.5x | 1.2x |
| Sun, 10 Jul 2022 | HK$658.3b | HK$515.0b | HK$52.3b | 8.9x | 12.6x | 1.3x |
| Tue, 07 Jun 2022 | HK$567.0b | HK$515.9b | HK$52.1b | 9x | 10.9x | 1.1x |
Price to Earnings Ratio
10.9x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 20.4x which is higher than its 3-year average PE of 14.8x.
- The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.2x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 18% per year over the last three years,
- Revenues have also declined 2.5% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | -0.59% | |
| Healthcare | 4.12% | |
| Pharma | 6.25% | |
| Pharma | 6.25% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1093 CSPC Pharmaceutical Group | HK$8.10 | 22.4% +HK$16.9b | 22.2% | PE20.3x | |
| 2096 Simcere Pharmaceutical Group | HK$12.84 | 24.2% +HK$6.2b | 119.1% | PE39.8x | |
| 1177 Sino Biopharmaceutical | HK$4.45 | 6.5% +HK$4.8b | 56.7% | PE38x | |
| 3933 United Laboratories International Holdings | HK$14.62 | 8.9% +HK$2.2b | 62.4% | PE9.2x | |
| 3692 Hansoh Pharmaceutical Group | HK$25.85 | 0.8% +HK$1.2b | 61.0% | PE32.3x |
